Hims vs Ro for GLP-1 weight loss

As of July 2026, Hims charges $39 for the first month of its Weight Loss Membership and $149 per month afterward. Medication is extra. Its current public medication page advertises starting prices of $149 per month for the Wegovy pill and Foundayo, $199 for the Wegovy pen, and $299 for either the Zepbound KwikPen or vial. These are starting medication prices, not all-in program prices, and the page says pricing may vary by dosage.

Ro also advertises a $39 first month. Its ongoing membership is $149 month to month or as low as $74 per month when an annual plan is prepaid. Medication remains separate. Ro lists the Wegovy pill at $149 for the first month and $199–$299 afterward, Foundayo at the same range, Zepbound KwikPen at $299 initially and $399–$449 afterward, and the Wegovy pen at $199 initially and $199–$399 afterward. Prepayment and dose can affect the price.

Compare the total over the period you realistically expect to use the service. A low introductory medication price can obscure the recurring membership fee, later-dose pricing, and the financial commitment attached to an annual plan.

As of July 2026, Hims publicly lists branded Wegovy pills and pens, Zepbound KwikPens and vials, Foundayo pills, and an Ozempic pill. Ro’s pricing page lists Wegovy pills and pens, Foundayo pills, Zepbound KwikPens, and Ozempic; its insurance page separately identifies the Zepbound autoinjector pen as an insurance-supported option. Availability still depends on the clinician’s assessment, state, fulfillment channel, and stock.

The oral products are not automatically compounded simply because they are pills. FDA labeling identifies Wegovy tablets as an approved semaglutide formulation, and FDA approved Foundayo, containing orforglipron, for long-term weight reduction in eligible adults in April 2026.

Neither provider’s current public medication-pricing page consulted for this comparison advertises a compounded GLP-1 as a standard option. Ro’s terms say compounded medication may be prescribed during national shortages, but that language does not establish that Ro currently offers one. FDA states that compounded drugs are not FDA approved and are not reviewed before marketing for safety, effectiveness, or quality. Ask for the exact product name, manufacturer or compounding pharmacy, and FDA-approval status before paying.

Hims is primarily a cash-pay service. Its terms say Hims, its medical groups, and participating platform entities do not submit claims to government or commercial insurance programs for services and products obtained through the platform. That can make billing more predictable, but it leaves the member responsible for the advertised membership and medication charges.

Ro offers insurance navigation for selected branded medications. As of July 2026, Ro says its concierge can check benefits, prepare prior-authorization paperwork, communicate with the insurer, and pursue an appeal after a denial. The medications currently identified for this support are the Wegovy pen, Zepbound autoinjector pen, and Ozempic. Coverage is not guaranteed, medication copays vary, and insurance does not cover the Ro Body membership.

Ro is therefore the stronger fit when potential insurance coverage could materially change the medication cost and you want help with the paperwork. Hims may fit better when you already expect to pay cash and prefer to compare published self-pay options without waiting for an insurance decision.

Hims includes an initial telehealth evaluation, monthly clinical check-ins, visits for medication adjustments when needed, unlimited provider messaging, and care-team support. Its medication page says a video or audio appointment may be required depending on the state; otherwise, much of the process can occur through intake forms and messaging. Hims also says response times may vary.

Ro’s terms describe up to 24 discrete medical consultations per year, secure messaging with a coach who is a Ro-affiliated healthcare provider, an onboarding curriculum, and laboratory testing when ordered. The same terms say providers review messages within 48 hours or sooner during weekday business hours and explicitly state that Ro Body is not a 24/7 on-call service.

Neither model replaces comprehensive primary or specialty care. Before enrolling, ask who reviews routine check-ins, how quickly urgent side-effect questions are escalated, when a live visit is required, how lab results are shared, and what happens if the platform decides it can no longer manage your treatment.

Hims and Ro both use automatic renewal. Hims requires cancellation at least two days before the next billing date. Canceling only a Hims medication plan does not cancel the membership, while canceling the membership also ends the active medication plan. Hims generally provides no refund for a partly used billing period or medication that has shipped. Prescriptions fulfilled through an outside service such as Gifthealth can carry separate billing and cancellation rules.

Ro requires cancellation at least 48 hours before renewal. Its membership fee is nonrefundable, and paid membership services continue through the current billing cycle; prescription access ends afterward. Ro also warns that membership may keep renewing even when a member is not requesting or receiving medication. Refill pricing can depend on the medication, dose, timing, insurance, and pharmacy channel.

Use this checkout checklist before choosing:

Based on the advertised structures as of July 2026, Hims is the cleaner match for someone expecting to self-pay, comfortable with app-based follow-up, and interested in its current range of branded injectable and oral options. The tradeoff is limited insurance handling and a $149 ongoing monthly membership on top of medication.

Ro is the more practical match when insurance coverage for Wegovy, Zepbound, or Ozempic is worth pursuing, or when prepaying for an annual membership produces meaningful savings. The tradeoffs are the annual commitment behind the lowest membership price, separate medication charges, and no guarantee that prior authorization will succeed.

Do not choose solely from the cheapest displayed first month. Compare the specific medication, later-month cost, refill conditions, care responsiveness, and exit terms that apply to your account. Make medication and health decisions with a licensed clinician who knows your medical history.

Ro's public pricing separates Body membership from GLP-1 medication cost. Hims public pages also show medication prices with a required weight-loss membership for certain offers. For both programs, the fair comparison is not the first button price; it is recurring membership plus medication plus any labs, shipping or refill charges.

Ro is often strongest as a brand-name and insurance-navigation comparison. Hims has moved toward broader FDA-approved access while describing limited compounded semaglutide availability in company materials. If a compounded product appears in either path, apply the FDA's unapproved GLP-1 warnings.

Start with Ro if insurance coverage and paperwork help are the main reasons you are shopping. Start with Hims if you are comparing a familiar direct-to-consumer telehealth brand and want to review multiple medication paths. In either case, keep checkout screenshots and final terms.